[
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Functional Outcomes",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Patient Preferences & Values",
    "Comparative Effectiveness",
    "Long-Term Monitoring & Follow-Up"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Financial & Economic Impact",
    "Personalized & Precision Medicine Factors",
    "Long-Term & Survivorship Considerations",
    "Comparative Effectiveness",
    "Ethical & Shared Decision-Making Factors",
    "Support Systems & Integrative Care",
    "Innovation & Future-Readiness"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Fit",
    "Treatment Accessibility & Equity",
    "Patient Preferences & Goals",
    "Comparative Effectiveness",
    "Long-Term Outcomes"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Economic & Logistical Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Comparative Value vs. Alternatives",
    "Long-Term & Survivorship Impact",
    "Patient Preferences & Shared Decision-Making"
  ],
  [
    "Clinical Efficacy & Outcomes",
    "Safety & Side Effects",
    "Treatment Modality & Convenience",
    "Cost & Financial Burden",
    "Quality of Life (QoL) Impact",
    "Patient Preferences & Goals",
    "Comparative Effectiveness",
    "Access & Equity Considerations",
    "Long-Term Monitoring & Survivorship",
    "Novel/Experimental Therapies (if applicable)"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Treatment Goals & Patient Preferences",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity",
    "Physician & Patient Trust in Evidence"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Treatment Accessibility & Equity",
    "Patient Preferences & Goals",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Treatment Goals & Preferences",
    "Comparative Effectiveness",
    "Accessibility & Equity",
    "Long-Term Outcomes & Survivorship"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Social & Support Systems"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Access & Equity"
  ],
  [
    "Clinical Effectiveness",
    "Safety & Tolerability",
    "Cost & Economic Burden",
    "Patient-Centered Outcomes",
    "Biomarker & Precision Medicine Value",
    "Comparative Effectiveness",
    "Access & Equity",
    "Long-Term Survivorship & Follow-Up"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Treatment Modality & Logistics",
    "Financial & Practical Considerations",
    "Long-Term & Survivorship Impact",
    "Comparative Value vs. Alternatives",
    "Emerging & Supportive Therapies"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Economic & Accessibility Factors",
    "Biomarker & Precision Medicine Value",
    "Comparative Effectiveness",
    "Long-Term Survivorship & Late Effects",
    "Ethical & Shared Decision-Making Considerations",
    "Healthcare System Impact"
  ],
  [
    "Clinical Effectiveness",
    "Safety & Side Effects",
    "Treatment Accessibility & Logistics",
    "Economic Burden",
    "Patient-Centered Outcomes",
    "Biomarker & Precision Medicine Fit",
    "Comparative Value vs. Alternatives",
    "Survivorship & Long-Term Health"
  ],
  [
    "Clinical Efficacy",
    "Safety and Tolerability",
    "Quality of Life (QoL) and Patient-Reported Outcomes (PROs)",
    "Treatment Burden and Convenience",
    "Cost and Financial Impact",
    "Biomarker and Subgroup Benefits",
    "Comparative Value",
    "Patient Preferences and Goals",
    "Survivorship and Long-Term Outcomes",
    "Healthcare System and Logistical Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Accessibility & Logistics",
    "Economic & Health System Impact",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term & Survivorship Considerations",
    "Comparative & Contextual Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Subgroup Benefits",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Social & Support Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Financial & Economic Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value (vs. Alternatives)",
    "Long-Term & Survivorship Impact",
    "Patient Preferences & Shared Decision-Making",
    "Healthcare System & Logistical Factors",
    "Ethical & Societal Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term & Survivorship Considerations",
    "Ethical & Psychosocial Support"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Treatment Goals & Preferences",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Fit",
    "Treatment Goals & Preferences",
    "Comparative Effectiveness",
    "Long-Term Outcomes",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Financial & Accessibility Considerations",
    "Comparative Value (vs. Alternatives)",
    "Long-Term & Survivorship Impact",
    "Patient Preferences & Shared Decision-Making",
    "Healthcare System & Societal Impact"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Logistics",
    "Patient-Specific Factors",
    "Quality of Life (QoL) & Functional Impact",
    "Financial & Practical Considerations",
    "Comparative & Alternative Options",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Values"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Patient Preferences & Shared Decision-Making",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship",
    "Equity & Access Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Financial & Economic Impact",
    "Personalization & Biomarker-Driven Therapy",
    "Long-Term Survivorship & Late Effects",
    "Patient Preferences & Shared Decision-Making",
    "Comparative Effectiveness & Alternatives",
    "Supportive Care & Integrative Services",
    "Healthcare System & Policy Factors"
  ],
  [
    "Clinical Effectiveness",
    "Safety & Tolerability",
    "Treatment Modality & Convenience",
    "Cost & Financial Burden",
    "Patient-Centered Factors",
    "Biomarker & Genomic Considerations",
    "Comparative Value vs. Alternatives",
    "Long-Term Health & Survivorship"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Economic Impact",
    "Biomarker & Personalized Medicine Value",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Healthcare System Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Survivorship & Long-Term Outcomes",
    "Patient Preferences & Values",
    "Social & Support Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Modality & Convenience",
    "Cost & Financial Burden",
    "Biomarker & Personalized Medicine Considerations",
    "Long-Term & Survivorship Impact",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Financial & Accessibility Considerations",
    "Personalization & Biomarker-Driven Value",
    "Comparative Value vs. Alternatives",
    "Ethical & Shared Decision-Making Factors",
    "Long-Term & Survivorship Impact"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Values",
    "Comparative Effectiveness",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Ethical & Access Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Factors",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Access & Equity"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Economic & Logistical Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term & Survivorship Impact",
    "Patient Preferences & Shared Decision-Making",
    "Healthcare System & Policy Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Economic Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Patient Preferences & Shared Decision-Making",
    "Comparative Evidence",
    "Long-Term Outcomes & Survivorship",
    "Equity & Access"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Accessibility",
    "Biomarker & Subgroup Relevance",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Novelty & Evidence Strength"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Ethical & Social Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Healthcare System & Logistical Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Accessibility & Equity",
    "Long-Term Outcomes & Survivorship"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Treatment Modality & Logistics",
    "Economic & Practical Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term & Survivorship Impact",
    "Comparative & Alternative Options",
    "Ethical & Shared Decision-Making Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Patient Preferences & Values",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity",
    "Novelty & Future Potential"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Subgroup Benefits",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Supportive Care & Multidisciplinary Needs"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Economic & Access Considerations",
    "Biological & Genomic Factors",
    "Treatment Modality-Specific Metrics",
    "Long-Term & Survivorship Impact",
    "Social & Ethical Dimensions",
    "Comparative Effectiveness"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Cost & Financial Impact",
    "Quality of Life (QoL) & Patient Experience",
    "Personalized & Genomic Factors",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Shared Decision-Making",
    "Comparative & Alternative Options",
    "Healthcare System & Logistical Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Cost & Financial Burden",
    "Quality of Life (QoL) & Patient Experience",
    "Personalized Medicine Factors",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship",
    "Ethical & Shared Decision-Making Considerations"
  ],
  [
    "Clinical Efficacy & Outcomes",
    "Safety & Side Effects",
    "Treatment Modality & Convenience",
    "Cost & Financial Impact",
    "Quality of Life (QoL) & Psychosocial Impact",
    "Patient Preferences & Shared Decision-Making",
    "Comparative Value (vs. Alternatives)",
    "Accessibility & Equity",
    "Long-Term Monitoring & Survivorship",
    "Ethical & Legal Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Value",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Equity & Access"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Fit",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Personalization & Biomarker Suitability",
    "Long-Term & Survivorship Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Cost & Financial Impact",
    "Quality of Life (QoL) & Patient Experience",
    "Personalized & Genomic Factors",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Shared Decision-Making",
    "Comparative & Alternative Therapies",
    "Healthcare System & Support Services"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Logistics",
    "Quality of Life (QoL) Impact",
    "Financial & Accessibility Considerations",
    "Patient Preferences & Values",
    "Comparative Value vs. Alternatives",
    "Long-Term Outcomes & Survivorship",
    "Ethical & Shared Decision-Making Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Economic & Access Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Values",
    "Comparative Effectiveness",
    "Ethical & Social Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Access & Equity Considerations",
    "Long-Term Monitoring & Survivorship Care"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Effectiveness",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Burden & Convenience",
    "Financial & Economic Impact",
    "Long-Term & Survivorship Considerations",
    "Personal & Cultural Preferences",
    "Comparative & Alternative Options",
    "Healthcare System & Access Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Cost & Financial Impact",
    "Quality of Life (QoL) & Patient Experience",
    "Personalized & Genomic Factors",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Shared Decision-Making",
    "Comparative & Alternative Therapies",
    "Healthcare System & Provider Factors",
    "Regulatory & Evidence-Based Support"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Burden & Convenience",
    "Financial & Accessibility Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term & Survivorship Impact",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making"
  ],
  [
    "Clinical Efficacy",
    "Safety and Tolerability",
    "Quality of Life (QoL) and Patient-Reported Outcomes (PROs)",
    "Treatment Burden",
    "Cost and Accessibility",
    "Biomarker and Subgroup Benefits",
    "Comparative Value",
    "Patient Preferences and Goals",
    "Long-Term Outcomes",
    "Novelty and Future Prospects"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Financial & Economic Impact"
  ],
  [
    "Clinical Efficacy & Outcomes",
    "Safety & Tolerability",
    "Treatment Modality & Convenience",
    "Cost & Financial Impact",
    "Patient Preferences & Values",
    "Comparative Effectiveness",
    "Biomarker & Precision Medicine Alignment",
    "Long-Term & Survivorship Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Treatment Accessibility & Logistics",
    "Economic & Financial Considerations",
    "Biological & Genomic Factors",
    "Comparative Effectiveness",
    "Long-Term Survivorship & Late Effects",
    "Patient Preferences & Shared Decision-Making",
    "Healthcare System & Policy Factors",
    "Social & Support Network Impact"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Comparative Effectiveness",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Accessibility",
    "Biomarker & Subgroup Benefits",
    "Comparative Value",
    "Patient Preferences & Values",
    "Long-Term Outcomes",
    "Ethical & Social Considerations"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Accessibility",
    "Cost & Financial Impact",
    "Quality of Life (QoL) & Patient Experience",
    "Personalized & Genomic Factors",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Shared Decision-Making",
    "Comparative & Alternative Therapies",
    "Healthcare System & Provider Factors",
    "Regulatory & Evidence-Based Support"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Accessibility",
    "Biomarker & Precision Medicine Alignment",
    "Comparative Effectiveness",
    "Patient Preferences & Values",
    "Long-Term Outcomes & Survivorship",
    "Social & Support Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalization",
    "Comparative Value",
    "Psychosocial & Supportive Care",
    "Long-Term Outcomes",
    "Patient Preferences & Goals"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Fit",
    "Comparative Effectiveness",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Social & Support Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes",
    "Treatment Accessibility & Convenience",
    "Financial & Economic Burden",
    "Personalized & Precision Medicine Factors",
    "Long-Term Survivorship & Late Effects",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Supportive Care & Integrative Services",
    "Healthcare System & Policy Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Patient-Centered Outcomes",
    "Treatment Modality & Logistics",
    "Economic & Practical Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term & Survivorship Impact",
    "Comparative & Alternative Options",
    "Shared Decision-Making & Preferences"
  ],
  [
    "Clinical Effectiveness",
    "Safety & Side Effects",
    "Economic & Accessibility",
    "Patient-Centered Outcomes",
    "Biomarker & Precision Medicine Value",
    "Treatment Modality Considerations",
    "Long-Term Survivorship & Follow-Up",
    "Ethical & Shared Decision-Making Factors"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Long-Term Outcomes & Survivorship",
    "Ethical & Social Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Accessibility & Equity",
    "Long-Term Outcomes"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Fit",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Social & Ethical Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Effectiveness",
    "Patient Preferences & Shared Decision-Making",
    "Survivorship & Long-Term Outcomes",
    "Ethical & Equity Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Value",
    "Comparative Value",
    "Patient Preferences & Goals",
    "Long-Term Outcomes",
    "Supportive Care & Survivorship"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Biomarker & Personalized Medicine Considerations",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Goals",
    "Long-Term Outcomes & Survivorship",
    "Healthcare System & Logistical Factors"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Logistics",
    "Patient-Specific Factors",
    "Quality of Life (QoL) & Psychosocial Impact",
    "Financial & Practical Considerations",
    "Comparative Value vs. Alternatives",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Shared Decision-Making"
  ],
  [
    "Clinical Efficacy & Survival Outcomes",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Biomarker & Subgroup Benefits",
    "Cost & Financial Impact",
    "Comparative Effectiveness",
    "Long-Term Survivorship & Late Effects",
    "Patient Preferences & Shared Decision-Making",
    "Real-World Evidence (RWE) & Clinical Trial Data"
  ],
  [
    "Clinical Efficacy & Safety",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Financial & Economic Impact",
    "Biomarker & Precision Medicine Considerations",
    "Comparative Effectiveness & Alternatives",
    "Long-Term Survivorship & Late Effects",
    "Patient Preferences & Shared Decision-Making",
    "Healthcare System & Logistical Factors",
    "Ethical & Societal Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Cost & Financial Impact",
    "Patient Preferences & Shared Decision-Making",
    "Comparative Effectiveness",
    "Long-Term Outcomes & Survivorship",
    "Accessibility & Equity",
    "Novelty & Future Potential"
  ],
  [
    "Clinical Efficacy & Safety",
    "Treatment Modality & Logistics",
    "Patient-Specific Factors",
    "Quality of Life (QoL) Impact",
    "Financial & Practical Considerations",
    "Comparative Value vs. Alternatives",
    "Long-Term Outcomes & Survivorship",
    "Patient Preferences & Goals"
  ],
  [
    "Clinical Effectiveness",
    "Safety & Tolerability",
    "Cost & Economic Burden",
    "Patient-Centered Outcomes",
    "Treatment Accessibility & Logistics",
    "Comparative Value",
    "Ethical & Societal Considerations"
  ],
  [
    "Clinical Efficacy",
    "Safety & Tolerability",
    "Quality of Life (QoL) & Patient-Reported Outcomes (PROs)",
    "Treatment Burden & Convenience",
    "Economic & Access Considerations",
    "Biomarker & Personalized Medicine Factors",
    "Long-Term Outcomes & Survivorship",
    "Comparative Value vs. Alternatives",
    "Patient Preferences & Shared Decision-Making",
    "Ethical & Social Considerations"
  ]
]